The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Open accessAbstract
Amyloid-β (Aβ) peptides are produced in high amounts during Alzheimer's disease, causing synaptic and memory dysfunction. However, they are also released in lower amounts in normal brains throughout life during synaptic activity. Here we show that low picomolar concentrations of a preparation containing both Aβ 42 monomers and oligomers cause a marked increase of hippocampal long-term potentiation, whereas high nanomolar concentrations lead to the well established reduction of potentiation. Picomolar levels of Aβ 42 also produce a pronounced enhancement of both reference and contextual fear memory. The mechanism of action of picomolar Aβ 42 on both synaptic plasticity and memory involves α7-containing nicotinic acetylcholine receptors. These findings strongly support a model for Aβ effects in which low concentrations play a novel positive, modulatory role on neurotransmission and memory, whereas high concentrations play the well known detrimental effect culminating in dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“picomolar concentrations of Aβ are sufficient to stimulate nicotinic receptors and subsequently LTP and learning and memory in healthy rodents (Puzzo et al., 2008, 2012; Morley et al., 2010)”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Puzzo et al., 2008
In the citing paper
“To address this concern, other studies injected picomolar concentrations of Aβ peptides into the mice, which also significantly enhanced synaptic plasticity and memory formation.394”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [394]
In the citing paper
“Remarkably, at sub-nanomolar doses, the effect on LTP is reversed, and Aβ markedly enhances LTP. Discovered by Arancio and colleagues in a detailed analysis (Puzzo et al., 2008), enhancement occurs over a narrow range of concentrations and is associated with presynaptic activation of alpha7 nicotinic receptors.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Puzzo et al., 2008
In the citing paper
“and synaptic transmission (Puzzo et al., 2008, 2011)”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Puzzo et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Research works printed but not linked: 2
- 1985, Exp Brain Res, 58, 11
- 2005, Methods Mol Biol, 299, 279
Cited by
Sorted by citations
Items 301–400 of 740
Alzheimer’s Disease: Drug Discovery
Huang, X. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020 · Cited by 49
Min, S. S., An, J., Lee, J.-H., Seol, G. H., Im, J. H., Kim, H.-S., Baik, T., & Woo, R. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.246 · Cited by 46
Goñi, F., Herline, K., Peyser, D., Wong, K., Ji, Y., Sun, Y., Mehta, P., & Wisniewski, T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-150 · Cited by 43
Hormesis and Amyloid-β Protein: Physiology or Pathology?
Morley, J. E., & Farr, S. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111928 · Cited by 45
Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy
Nehls, M. (2016) · Journal of Molecular Psychiatry · doi:10.1186/s40303-016-0018-8 · Cited by 41
Impaired β-Amyloid Secretion in Alzheimer's Disease Pathogenesis
Tampellini, D., Rahman, N., Lin, M. T. S., Capetillo‐Zarate, E., & Gouras, G. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2986-11.2011 · Cited by 41
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Jean, Y. Y., Baleriola, J., Fà, M., Hengst, U., & Troy, C. M. (2015) · Journal of Visualized Experiments · doi:10.3791/52805 · Cited by 47
Self-citationLi, X., Uemura, K., Hashimoto, T., Nasser-Ghodsi, N., Arimon, M., Lill, C. M., Palazzolo, I., Krainc, D., Hyman, B. T., & Berezovska, O. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.002 · Cited by 38
A β‐amyloid oligomer directly modulates P/Q‐type calcium currents inXenopusoocytes
Mezler, M., Barghorn, S., Schoemaker, H., Gross, G., & Nimmrich, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01646.x · Cited by 43
Endogenous amyloidogenesis in long-term rat hippocampal cell cultures
Bertrand, S. J., Aksenova, M. V., Aksenov, M. Y., Mactutus, C. F., & Booze, R. M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-38 · Cited by 40
Peterman, J. L., White, J. D., Calcagno, A., Hagen, C. W., Quiring, M. E., Paulhus, K., Gurney, T., Eimerbrink, M. J., Curtis, M., Boehm, G. W., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112366 · Cited by 41
Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology
Patnaik, A., Zagrebelsky, M., Korte, M., & Holz, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70153-4 · Cited by 40
Ding, Y., Ko, M. H., Pehar, M., Kotch, F. W., Peters, N. R., Luo, Y., Salamat, S. M., & Puglielli, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.310136 · Cited by 40
Mota, S. I., Ferreira, I. L., Pereira, C., Oliveira, C. R., & Rego, A. C. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455322 · Cited by 42
Tropea, M. R., Puma, D. D. L., Melone, M., Gulisano, W., Arancio, O., Grassi, C., Conti, F., & Puzzo, D. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102154 · Cited by 42
Self-citationSanchez-Varo, R. M., Sánchez‐Mejías, E., Fernandez-Valenzuela, J. J., Castro, V. D., Mejias‐Ortega, M., Gómez-Arboledas, Á., Jiménez, S., Sanchez-Mico, M. V., Trujillo‐Estrada, L., Moreno‐González, I., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.752594 · Cited by 42
Dynamin 1 Is Required for Memory Formation
Fà, M., Staniszewski, A., Saeed, F., Francis, Y. I., & Arancio, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091954 · Cited by 39
Self-citationThompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 39
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Singh, M. K., Shin, Y., Ju, S., Han, S., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136901 · Cited by 43
A Reliable Way to Detect Endogenous Murine β-Amyloid
Teich, A. F., Patel, M., & Arancio, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055647 · Cited by 41
Self-citationMechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer’s disease
Devi, L., & Ohno, M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.59 · Cited by 38
Ntsapi, C., Lumkwana, D., Swart, C., du Toit, A., & Loos, B. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.002 · Cited by 39
Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.635880 · Cited by 43
Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
Fernández-Pérez, E. J., Muñoz, B., Bascuñán, D., Peters, C., Riffo-Lepe, N., Flores-Espinoza, M. P., Morgan, P. J., Filippi, C., Bourboulou, R., Sengupta, U., et al. (2021) · Aging Cell · doi:10.1111/acel.13455 · Cited by 38
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
Sinopoli, A., Giuffrida, A., Tomasello, M. F., Giuffrida, M. L., Leone, M., Attanasio, F., Caraci, F., Bona, P. D., Николаевна, Н. И., Saviano, M., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600243 · Cited by 38
Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
Imbimbo, B. P., Frigerio, E., Breda, M., Fiorentini, F., Fernández, M., Sivilia, S., Giardino, L., Calzà, L., Norris, D., Casula, D., et al. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182622ace · Cited by 37
Paumier, J.-M., Py, N. A., García-González, L., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801076r · Cited by 40
LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity
Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naudé, P., de Haan, A., Borbély, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1297 · Cited by 37
Activation of Protein Kinase C Isozymes for the Treatment of Dementias
Sun, M., & Alkon, D. L. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00008-8 · Cited by 39
Parikh, V., Bernard, C. S., Naughton, S. X., & Yegla, B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.046 · Cited by 37
Liu, L., Yu, J., Li, L., Zhang, B., Liu, L., Wu, C., Jong, A., Mao, D.-A., & Huang, S. (2017) · Scientific Reports · doi:10.1038/srep40467 · Cited by 36
Salgado-Puga, K., Rodríguez-Colorado, J., Prado-Alcalá, R. A., & Peña‐Ortega, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160543 · Cited by 35
Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid
Marsh, J., Bagol, S. H., Williams, R. S. B., Dickson, G., & Alifragis, P. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.011 · Cited by 36
BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines
Blume, T., Filser, S., Jaworska, A. M., Blain, J., Koenig, G., Moschke, K., Lichtenthaler, S. F., & Herms, J. W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00229 · Cited by 37
“Untangling” Alzheimer's Disease and Epilepsy
Scharfman, H. E. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.5.178 · Cited by 36
Krstic, D., & Knuesel, I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-62 · Cited by 38
Seong, S. H., Paudel, P., Jung, H. A., & Choi, J. S. (2019) · Marine Drugs · doi:10.3390/md17110600 · Cited by 35
Lascio, S. D., Fornasari, D., & Benfante, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073463 · Cited by 35
Martinsson, I., Quintino, L., Garcia, M. G., Konings, S. C., Torres-Garcia, L., Svanbergsson, A., Stange, O., England, R., Deierborg, T., Li, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.946297 · Cited by 35
Asim, A., Jastrzębski, M. K., & Kaczor, A. A. (2025) · Molecules · doi:10.3390/molecules30142975 · Cited by 43
Fragile X Syndrome and Alzheimers Disease: Another Story About APP and β -Amyloid
Malter, J. S., Ray, B. C., Westmark, P. R., & Westmark, C. J. (2010) · Current Alzheimer Research · doi:10.2174/156720510791050957 · Cited by 34
Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer’s disease patients?
Panza, F., Lozupone, M., Bellomo, A., & Imbimbo, B. P. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100948 · Cited by 34
Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
Giuffrida, M. L., Tomasello, M. F., Caraci, F., Chiechio, S., Nicoletti, F., & Copani, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8313-6 · Cited by 35
A novel mechanism for cyclic adenosine monophosphate–mediated memory formation: Role of amyloid beta
Ricciarelli, R., Puzzo, D., Bruno, O., Canepa, E., Gardella, E., Rivera, D., Privitera, L., Domenicotti, C., Marengo, B., Marinari, U. M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24130 · Cited by 32
Self-citationSun, J. L., Stokoe, S. A., Roberts, J. P., Sathler, M. F., Nip, K., Shou, J., Ko, K. H., Tsunoda, S., & Kim, S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.005 · Cited by 36
Feng, B., Freitas, A. E., Gorodetski, L., Wang, J., Tian, R., Lee, Y. R., Grewal, A. S., & Zou, Y. (2021) · Science Advances · doi:10.1126/sciadv.abh2307 · Cited by 38
Wang, Y., Zhang, G., Zhou, H., Barakat, A., & Querfurth, H. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008366 · Cited by 34
Rammes, G., Mattusch, C., Wulff, M., Seeser, F., Kreuzer, M., Zhu, K., Deussing, J. M., Herms, J. W., & Parsons, C. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.003 · Cited by 37
Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease
Wesson, D. W., Nixon, R. A., Levy, E., & Wilson, D. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8177-1 · Cited by 34
Sellés, M. C., Fortuna, J. T. S., Cercato, M. C., Santos, L. E., Domett, L., Bitencourt, A. L. B., Carraro, M. F., de Souza, A. S., Janíčková, H., Azevedo, C. V., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.002 · Cited by 35
Self-citationBeta‐amyloid 1‐42 monomers, but not oligomers, produce PHF ‐like conformation of Tau protein
Manassero, G., Guglielmotto, M., Zamfir, R. I., Borghi, R., Colombo, L., Salmona, M., Perry, G. L., Odetti, P. R., Arancio, O., Tamagno, E., et al. (2016) · Aging Cell · doi:10.1111/acel.12500 · Cited by 32
Self-citationGarcía‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 34
Pannuzzo, M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12373 · Cited by 34
A unifying framework for amyloid-mediated membrane damage: The lipid-chaperone hypothesis
Tempra, C., Scollo, F., Pannuzzo, M., Lolicato, F., & Rosa, C. L. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140767 · Cited by 32
Decourt, B., Noorda, K., Noorda, K. J., Shi, J., & Sabbagh, M. N. (2022) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265626 · Cited by 33
Deutsch, S. I., Burket, J. A., Urbano, M. R., & Benson, A. D. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.005 · Cited by 32
Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice
Kittelberger, K. A., Piazza, F., Tesco, G., & Reijmers, L. G. J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029940 · Cited by 35
Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic Orchestra
Fagiani, F., Lanni, C., Racchi, M., Pascale, A., & Govoni, S. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190771 · Cited by 34
Postu, P. A., Gorgan, L., Cioancă, O., Ruß, M., Mikkat, S., Glocker, M. O., & Hriţcu, L. (2020) · Antioxidants · doi:10.3390/antiox9100919 · Cited by 32
Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease
Qin, P., Ran, Y., Liu, Y., Wei, C., Luan, X., Niu, H., Peng, J., Sun, J., & Wu, J. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106090 · Cited by 31
Hermann, D. J., Mezler, M., Müller, M., Wicke, K. M., Groß, G., Draguhn, A., Bruehl, C., & Nimmrich, V. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.030 · Cited by 31
Parsons, C. G., Ruitenberg, M., Freitag, C. E., Sroka, K., Russ, H., & Rammes, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.038 · Cited by 31
Rammes, G., Seeser, F., Mattusch, K., Zhu, K., Haas, L. T., Kummer, M. P., Heneka, M. T., Herms, J. W., & Parsons, C. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.021 · Cited by 30
Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology
Glass, D. J., & Arnold, S. E. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2408 · Cited by 29
Beta-amyloid short- and long-term synaptic entanglement
Lanni, C., Fagiani, F., Racchi, M., Preda, S., Pascale, A., Grilli, M., Allegri, N., & Govoni, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.018 · Cited by 29
Navigating the dementia landscape: Biomarkers and emerging therapies
Maheshwari, S., Singh, A., Ansari, V. A., Mahmood, T., Wasim, R., Akhtar, J., & Verma, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102193 · Cited by 30
O’Nuallain, B., Klyubin, I. V., Donald, J. M. M., Foster, J. S., Welzel, A. T., Barry, A. E., Dykoski, R. K., Cleary, J. P., Gebbink, M. F. B. G., Rowan, M. J., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07389.x · Cited by 33
Jin, I., Puthanveettil, S. V., Udo, H., Karl, K. A., Kandel, E. R., & Hawkins, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206914109 · Cited by 31
Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
Dietrich, K., Bouter, Y., Müller, M., & Bayer, T. A. (2018) · Molecules · doi:10.3390/molecules23040718 · Cited by 30
Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
Yang, H., Li, J., Li, X., Ma, L., Hou, M., Zhou, H., & Zhou, R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.927530 · Cited by 33
Perez, F. P., Bose, D., Maloney, B., Nho, K. T., Shah, K., & Lahiri, D. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131544 · Cited by 31
Mehta, T. K., Dougherty, J. J., Wu, J., Choi, C. H., Khan, G. M., & Nichols, R. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06070.x · Cited by 30
Barucker, C., Bittner, H. J., Chang, P. K. ‐., Cameron, S., Hancock, M. A., Liebsch, F., Hossain, S., Harmeier, A., Shaw, H. S., Charron, F. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15410 · Cited by 32
Changing Perspectives on Alzheimer's Disease: Thinking Outside the Amyloid Box
D’Alton, S., & George, D. R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110089 · Cited by 31
Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia
Rajji, T. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1550074 · Cited by 30
Jęśko, H. M., Cieślik, M., Gromadzka, G., & Adamczyk, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104853 · Cited by 30
Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission
Kreis, A., Desloovere, J., Suelves, N., Pierrot, N., Yerna, X., Issa, F., Schakman, O., Gualdani, R., de Clippele, M., Tajeddine, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97144-3 · Cited by 29
Forest, K. H., Alfulaij, N., Arora, K., Taketa, R., Sherrin, T., Todorovic, C., Lawrence, J. L. M., Yoshikawa, G. T., Ng, H. L., Hruby, V. J., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14257 · Cited by 28
Arora, K., Alfulaij, N., Higa, J. K., Panee, J., & Nichols, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453746 · Cited by 29
Parsons, C. G., & Rammes, G. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1313832 · Cited by 29
Asam, K. R., Staniszewski, A., Zhang, H., Melideo, S. L., Mazzeo, A., Voronkov, M. V., Huber, K. L., Pérez, E., Stock, M. B., Stock, J. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189413 · Cited by 28
Self-citationSecond Sphere Interactions in Amyloidogenic Diseases
Roy, M., Nath, A. K., Pal, I., & Dey, S. G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00941 · Cited by 29
The elusive nature and diagnostics of misfolded Aβ oligomers
Cerasoli, E., Ryadnov, M. G., & Austen, B. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00017 · Cited by 30
Wang, H., Song, L., Lee, A., Laird, F. M., Wong, P. C., & Lee, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1070-10.2010 · Cited by 28
Panza, F., Frisardi, V., Capurso, C. A., D’Introno, A., Colacicco, A. M., Palo, A. D., Imbimbo, B. P., Vendemiale, G., Capurso, A., & Solfrizzi, V. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.48 · Cited by 27
Berge, G., Sando, S. B., Albrektsen, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., & White, L. R. (2016) · BMC Neurology · doi:10.1186/s12883-016-0706-0 · Cited by 29
Willén, K. I., Sroka-Oleksiak, A., Takahashi, R. H., & Gouras, G. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170262 · Cited by 28
A Toxic Conformer of Aβ42 with a Turn at 22–23 is a Novel Therapeutic Target for Alzheimer’s Disease
Izuo, N., Kasahara, C., Murakami, K., Kume, T., Maeda, M., Irie, K., Yokote, K., & Shimizu, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11671-6 · Cited by 28
Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity
Accorroni, A., Rutigliano, G., Sabatini, M., Frascarelli, S., Borsò, M., Novelli, E., Bandini, L., Ghelardoni, S., Saba, A., Zucchi, R., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0255 · Cited by 28
Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer’s Disease?1
Kuhn, A. J., & Raskatov, J. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191201 · Cited by 31
Wang, Y., Zhang, M., Moon, C., Hu, Q., Wang, B., Martin, G. M., Sun, Z. S., & Wang, H. (2009) · Learning & Memory · doi:10.1101/lm.1499309 · Cited by 28
Is It the Twilight of BACE1 Inhibitors?
Hrabinova, M., Pejchal, J., Kucera, T., Jun, D., Schmidt, M., & Soukup, O. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200503023323 · Cited by 28
Repo, A., Eyvindson, K., Halme, P., & Mönkkönen, M. (2020) · Canadian Journal of Forest Research · doi:10.1139/cjfr-2019-0284 · Cited by 27
Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 29
Canepa, E., Domenicotti, C., Marengo, B., Passalacqua, M., Marinari, U. M., Pronzato, M. A., Fedele, E., & Ricciarelli, R. (2013) · IUBMB Life · doi:10.1002/iub.1109 · Cited by 27
Stoiljković, M., Kelley, C., Hajos, G. P., Nagy, D., Koenig, G., Leventhal, L., & Hajós, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.021 · Cited by 25
Rizzello, E., Pimpinella, D., Pignataro, A., Titta, G., Merenda, E., Saviana, M., Porcheddu, G. F., Paolantoni, C., Malerba, F., Giorgi, C., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106106 · Cited by 26
Rammes, G., Gravius, A., Ruitenberg, M., Wegener, N., Chambon, C., Sroka, K., Jeggo, R., Staniaszek, L. E., Spanswick, D. C., O‘Hare, E., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.037 · Cited by 51
Molecular Mechanism and Kinetics of Amyloid-β42 Aggregate Formation: A Simulation Study
Man, V. H., He, X., Ji, B., Liu, S., Xie, X., & Wang, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00473 · Cited by 26
Metadata
- Authors
- Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Catania (IT)
- Columbia University (US)
- Corresponding author
- Arancio, Ottavio
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-12-31
- Volume
- 28
- Issue
- 53
- Pages
- 14537-14545
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2673049
- OpenAlex
- W2078917784
- Cited by
- 740
- References
- 56
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 41 · 2023: 38 · 2022: 40 · 2021: 45 · 2020: 49 · 2019: 44 · 2018: 38 · 2017: 46 · 2016: 46 · 2015: 50 · 2014: 51 · 2013: 42 · 2012: 44
- FWCI
- 28.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- Alzheimer's Association (NIRG-07-59597)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS040045, R01NS049442, NS049442)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- amyloid-beta, synaptic plasticity, long-term potentiation, hippocampus, memory, fear memory, contextual fear, alpha7 nicotinic acetylcholine receptor, Alzheimer's disease, amyloid-beta oligomers, neurotransmission
- MeSH terms
- Analysis of Variance, Animals, Bungarotoxins, Dose-Response Relationship, Drug, Electric Stimulation, Hippocampus, Humans, Male, Mecamylamine, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Peptide Fragments, Receptors, Nicotinic, Synapses, 2-Amino-5-phosphonovalerate, Amyloid beta-Peptides, Mice, Knockout, Patch-Clamp Techniques, Excitatory Amino Acid Antagonists, Nicotinic Antagonists, Maze Learning, Excitatory Postsynaptic Potentials, Mice, alpha7 Nicotinic Acetylcholine Receptor, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
